Oxford Performance Materials launched the first two grades of its OXFAB 3D printing technology for aerospace and industrial applications — OXFAB-N and OXFAB-ESD.
What will happen in the medical device industry over the next few years? Zacks Equity Research analyzed the current situation and where the field is headed in the future.
Physician relationships with pharmaceutical and device companies are under scrutiny again, this time among eye surgeons.
The OtisMed plea agreement with the government over distributing their knee system without Food and Drug Administration clearance includes a side "non-prosecution" agreement with Stryker, which purchased OtisMed without knowledge of this incident, according to Corporate Crime Reporter.
Physicians sit on the Food and Drug Administration's panel for device clearances, and some of those physicians have financial ties to device companies. Does that influence their decisions?
Aurora Spine received the Health Canada Medical Device License for its ZIP Interspinous Fusion System.
Mazor Robotics received three purchase orders for its Renaissance robot-assisted systems.
Intrinsic Therapeutics completed patient enrollment in the company's randomized superiority clinical trial of the Barricaid anular closure device.
The first surgery performed with the Minimus Spine Triojection System was performed in Italy.
Amedica has closed its underwritten public offering that began on Nov. 26, 2014.